Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.51 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.42 |
| ▸ | S1PR5 | Q9H228 | 14/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 12/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15945890 | 0.95 | ALOX5 (0.47) | ALOX5GSTP1S1PR5S1PR4HSD17B1 | |
| SCHEMBL17944381 | 0.90 | ALOX5 (0.46) | ALOX5GSTP1S1PR5S1PR4HSD17B1 | |
| SCHEMBL17167404 | 0.89 | ALOX5 (0.64) | ALOX5GSTP1S1PR5S1PR4HSD17B1 | |
| SCHEMBL10018879 | 0.89 | ALOX5 (0.50) | ALOX5GSTP1S1PR5S1PR4HSD17B1 | |
| SCHEMBL17944371 | 0.89 | ALOX5 (0.44) | ALOX5GSTP1S1PR5S1PR4HSD17B1 | |
| SCHEMBL22706347 | 0.89 | ALOX5 (0.44) | ALOX5GSTP1S1PR5S1PR4HSD17B1 | |
| SCHEMBL21190410 | 0.88 | ALOX5 (0.44) | ALOX5GSTP1S1PR5S1PR4 | |
| SCHEMBL15893274 | 0.88 | ALOX5 (0.51) | ALOX5GSTP1S1PR5S1PR4 | |
| SCHEMBL18086206 | 0.88 | ALOX5 (0.66) | ALOX5GSTP1S1PR5S1PR4HDAC4 | |
| SCHEMBL23449000 | 0.88 | ALOX5 (0.40) | ALOX5GSTP1S1PR5S1PR4HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10038152-B2 | Organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2018-07-31 | — | — | US | disclosed |
| US-10038152-B2 | Organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2018-07-31 | — | — | US | disclosed |
| US-9899613-B2 | Organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2018-02-20 | — | — | US | disclosed |
| US-9899613-B2 | Organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2018-02-20 | — | — | US | disclosed |
| EP-2939289-B1 | ORGANIC LIGHT-EMITTING ELEMENT | CANON KK (JP) | 2017-07-26 | — | — | EP | disclosed |
| US-20150357586-A1 | ORGANIC LIGHT-EMITTING ELEMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-10 | — | — | US | disclosed |
| US-20150357586-A1 | ORGANIC LIGHT-EMITTING ELEMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-10 | — | — | US | disclosed |
| US-20150295188-A1 | ORGANIC LIGHT-EMITTING ELEMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-10-15 | — | — | US | disclosed |
| US-20150295188-A1 | ORGANIC LIGHT-EMITTING ELEMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-10-15 | — | — | US | disclosed |
| WO-2014123238-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2014-08-14 | — | — | WO | disclosed |
| WO-2014112658-A1 | ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2014-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10038152-B2 | Organic light-emitting element | NFE2L2, EML4, LEF1 | ALOX5 1144/4885GSTP1 1924/4885S1PR5 4848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.